国产精品久久这里只有精品,一起射福利,日本一区二区三区中文字幕

Study on Tirzepatide Weight Loss Mechanism Tirzepatide A new study in Cell Metabolism reveals how Tirzepatide, the most effective FDA-approved weight loss drug, works by increasing fat oxidation and reducing appetite without impacting metabolic adaptation in obese individuals.
2024 Global Top 10 Pharmaceutical Companies Market Trend The 2024 global ranking of the top 10 pharmaceutical companies showcases the continued strength of industry leaders like Johnson & Johnson, Roche, and Merck. Pfizer, AstraZeneca, and Eli Lilly also maintain strong positions with impressive growth and strategic investments.
Top 10 Pharmaceutical Giants' R&D Investments in 2024 Market Trend In 2024, pharmaceutical giants face a quiet battle over innovation and efficiency. From Merck’s 41% R&D drop to AbbVie’s bold growth, their strategies and investments reveal shifting power in the industry. A glimpse into the future of drug development.
Top 10 Global Pharmaceutical Giants in Autoimmune Business in 2024 Autoimmune The autoimmune sector saw explosive growth in 2024, with mergers and acquisitions skyrocketing by 150%. Giants like AbbVie, J&J, and Eli Lilly are reshaping the landscape. Explore the Top 10 revenue rankings in the autoimmune business and future trends.
Big Pharma -Waiting for the other Shoe to Drop Biotech Explore the shifting landscape of big pharma as clinical trial results, patent cliffs, and innovative therapies shape 2025. Discover how giants like Eli Lilly, Pfizer, and Novo Nordisk navigate challenges and opportunities in weight loss, oncology, and vaccines.
Top 10 Diabetes Medications to Watch in 2024 Diabetes Discover the top 10 diabetes medications of 2024, including Ozempic, Jardiance, and Mounjaro. Learn about their sales, innovations, and why they're leading in the treatment of diabetes and related conditions.
Eli Lilly Q3 2024 Financial statements Financial statements Eli Lilly's Q3 2024 report reveals strong growth with $31.5 billion in revenue, driven by $11 billion in sales from tirzepatide products Mounjaro and Zepbound, Mounjaro's sales doubled. With an expanded production capacity, Eli Lilly projecting a market potential of $150 billion by 2030.
Next-Generation Weight Loss Drug Star on the Rise, BD Expected to Reach Full Capacity Weight loss drugs? The weight loss drug market is heating up, with Eli Lilly, Novo Nordisk, and Chinese pharma companies competing in research and development. ActRII-targeted drugs, combining fat loss and muscle gain. Laekna's LAE102 has shown promising results, driving a 40% surge in its stock.
MNC Profiles: Who Values ??the Chinese Market Most? AstraZeneca Explore the competitive landscape of multinational pharmaceutical companies (MNCs) in China’s booming healthcare market. Delves into MNC revenue trends, strategies, and insights, highlighting which companies value the Chinese market most.
Expansion of Potential Blockbuster Drug Supply with 1.5 Billion RMB Additional Investment in China Eli Lilly Lilly China is investing 1.5 billion RMB to expand its Suzhou plant, boosting production for type 2 diabetes and obesity drugs. This is part of Lilly’s largest global capacity upgrade, enhancing supply and creating high-quality jobs in China.

< Pre 123 Next >

Articles Archives

Hot Articles

All Categories

Agri & Industry Cosmetic Laboratory Pharmaceutical Food

永久免费毛片_亚洲成人看片_亚洲春色另类_亚洲综合免费视频_最新高清无码专区_午夜影院a